Blue Cross Blue Shield MA TENS TAPS Coverage Update

Coverage Criteria for TENS and TAPS

Medically Necessary Indications

Covered when ALL of the following are met:

Initial TENS trial

A trial of transcutaneous electrical nerve stimulation (TENS) of at least 30 days is performed and monitored by a physician30 days
Refractory chronic pain is present (pain causing significant disruption of function)

Continuation of TENS

Clinical summary documents perceived pain intensity with and without TENS (e.g., ≥2-point or 30% improvement on VAS)
Documentation of ongoing medication requirements and other modalities in use for pain control
Actual device use recorded (frequency and duration) during the trial

Investigational — Investigational / Not Covered Indications

Investigational / Not Covered Indications:

Investigational indications: TENS is investigational for the management of acute pain (e.g., postoperative or during labor and delivery), and for the prevention or treatment of migraine headache

TENS is investigational for the management of attention deficit hyperactivity disorder (ADHD)

Transcutaneous afferent patterned stimulation (TAPS) is investigational for essential tremor and for action tremor associated with Parkinson disease

The use of TENS or TAPS for any other condition, including but not limited to the treatment of dementia, is investigational

The policy designates several indications for investigational status. Specifically, TENS is considered investigational for management of acute pain (including postoperative and labor/delivery), for the prevention or treatment of migraine headache, and for the management of attention deficit hyperactivity disorder (ADHD). The policy also states that the use of TENS or TAPS for any other condition, including but not limited to dementia, is investigational. Additionally, TAPS is listed as investigational for essential tremor and for action tremor associated with Parkinson disease.

Policy history documents multiple updates adding investigational indications. Notably, in 5/2022 new investigational indications were added for TENS for essential tremor and attention deficit hyperactivity disorder. Subsequent reviews (2024–2026) separated action tremor associated with Parkinson disease from essential tremor and explicitly added policy statements designating TAPS as investigational for both essential tremor and action tremor associated with Parkinson disease.

The policy cites CMS coverage documents and national guidelines as reference material. Relevant CMS documents referenced include the CMS National Coverage Determination (NCD) for TENS and the CMS decision memo(s) pertaining to assessment and coverage of electrical nerve stimulation therapies; these references may contain additional coverage considerations or exclusions to be reviewed when applying this policy.

Operationally, the policy treats indications designated as investigational as having insufficient evidence to support coverage. The document explicitly states that TENS and TAPS uses listed as investigational (for example, acute pain, migraine, ADHD, essential tremor, and action tremor of Parkinson disease) are considered investigational based on available evidence.

The excerpt does not include separate, explicit ‘not medically necessary’ statements for specific procedures; instead, the policy history and current statements designate particular uses as investigational. Those investigational designations are functionally treated as lacking sufficient evidence to meet medical necessity criteria in this policy context.

Coding and Billing

HCPCS CodesHCPCS

A4595	Electrical stimulator supplies, 2 lead, per month, (e.g., TENS, NMES).
A4630	Replacement batteries, medically necessary, transcutaneous electrical stimulator, owned by patient
E0720	Transcutaneous electrical nerve stimulator (TENS) device, two lead, localized stimulation.
E0730	Transcutaneous electrical nerve stimulation (TENS) device, four or more leads, for multiple nerve stimulation.
E0731	Form-fitting conductive garment for delivery of TENS or NMES (with conductive fibers separated from the patient's skin by layers of fabric

CPT Codes (investigational)CPTExperimental

0278T

Transcutaneous electrical modulation pain reprocessing (eg, scrambler therapy), each treatment session (includes placement of electrodes)

Provider Actions, Authorization, and Documentation

Prior Authorization

Prior Authorization / Authorization Requirements

Prior authorization (precertification) requirements vary by setting and product. For services described in this policy: • Inpatient — precertification/preauthorization IS REQUIRED for all products when the procedure is performed inpatient. • Outpatient — Commercial Managed Care (HMO and POS), PPO, and Indemnity: prior authorization is not required for outpatient services described in this policy. Note: this document does not specify any step therapy requirements.

Inpatient: precertification/preauthorization REQUIRED for all products when performed inpatient
Outpatient: Commercial Managed Care (HMO and POS), PPO, and Indemnity = prior authorization NOT required for outpatient services described here
No step therapy requirements are described in this policy excerpt

Documentation Required

Required Documentation for Trial and Continuation

Documentation necessary to support an initial therapeutic trial of TENS and continued coverage must be present in the medical record. Required elements include an initial assessment, prior treatments, and a clear treatment plan for TENS; and a clinical summary of the trial demonstrating efficacy and compliance for continuation.

Conservative Treatment Prerequisites

Required before TENS trial

Conservative treatment required before initiating a TENS therapeutic trial:

At least 3 months of conservative medical therapy (e.g., NSAIDs, ice, rest, and/or physical therapy) has been tried and failed>= 3 months

Conservative prerequisites absent in some document portions

Document note:

This portion of the document does not specify additional conservative therapy prerequisites for TENS or other procedures

Conservative prerequisites — additional note indicating 0 top-level nodes in excerpt

Conservative therapy references (no top-level prerequisites specified in these excerpts):

Frequency and Quantity Limits

Frequency limits

Frequency limits statedNo frequency limits stated in the policy excerpt.

Frequency limit sourcePolicy frequency_limits module — 'No frequency limits stated in this excerpt.'

Implication for authorizationNo periodic/annual or per-procedure numeric limits specified; follow general coverage and documentation requirements for trials and continuation.

Imaging and Diagnostic Requirements

Note

No imaging required per policy excerpt

No imaging requirements are specified in the cited portions of the policy.

Documentation Required

Guideline references may include imaging guidance — document if relied upon

Guidelines for spinal conditions and non‑surgical management are referenced (NASS, NICE, OARSI) and may contain imaging considerations, but the policy chunks do not state specific imaging requirements.

Referenced guideline documents include NASS Diagnosis and Treatment of Low Back Pain and NICE guidance which often discuss imaging as part of evaluation.

Background on TENS and TAPS

Transcutaneous electrical nerve stimulation (TENS) and transcutaneous afferent patterned stimulation (TAPS) are noninvasive neuromodulation techniques that apply electrical stimulation to the skin and can be self‑administered. These modalities have been used in attempts to manage chronic and acute pain and other neurologic symptoms; TENS mechanisms described in the literature include modulation of pain pathways and endogenous analgesic release. (See policy description and background references for details.)

Key Definitions

Refractory chronic pain — definition and conservative therapy examples

DefinitionRefractory chronic pain: pain that causes significant disruption of function and has not responded to at least 3 months of conservative therapy (including NSAIDs, ice, rest, and/or physical therapy).

Required conservative therapy prior to TENS trialAt least 3 months of conservative medical therapy must be tried and failed before initiating a TENS trial.

Examples of conservative therapiesNonsteroidal anti-inflammatory medications (NSAIDs), ice, rest, and physical therapy.

TENS trial monitoringA trial of TENS of at least 30 days must be monitored by a physician to establish efficacy for refractory chronic pain.

TAPS — definition and investigational status

Definition

Not Covered / Excluded Uses

Not covered under this policy are several indications specified as investigational: TENS for acute pain (including postoperative or during labor and delivery), TENS for prevention or treatment of migraine headache, and TENS for ADHD. The policy also specifies TAPS as investigational for essential tremor and action tremor associated with Parkinson disease, and states that use of TENS or TAPS for other conditions such as dementia is investigational.

OpenPayer

Transcutaneous Electrical Nerve Stimulation (TENS) and Transcutaneous Afferent Patterned Stimulation (TAPS) Coverage Criteria